Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06297967

Acetic Acid 2% Solution for Skin Ulcers

Acetic Acid in Cutaneous Ulcers. A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
Consorci Sanitari de l'Alt Penedès i Garraf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this clinical trial is to assess the effectiveness of acetic acid in patients suffering from chronic cutaneous ulcers with biofilm. The primary question it seeks to address is whether acetic acid (as a 2% topical solution) is superior to the current standard treatment for chronic cutaneous ulcers with biofilm at our center (Prontosan®). Participants will be randomly assigned to receive either the acetic acid solution treatment or the standard current treatment.

Conditions

Interventions

TypeNameDescription
DRUGAcetic AcidThe intervention treatment will consist of cleaning with water and soap, application of a compress soaked in 2% dilution of glacial acetic acid (CAS 64-19-7) for 15 minutes, irrigation with distilled water, application of peri-ulcer barrier cream or spray, and the application of ActicoatⓇ on the ulcer bed. Depending on the amount of exudate, more or less alginate will be added as a secondary dressing. A tertiary dressing of polyurethane foam or bandage will be applied according to the area and the nurse's discretion.
DRUGProntosanThe treatment includes ulcer cleansing with water and soap, application of ProntosanⓇ compress for 15 minutes, subsequent irrigation with distilled water, application of peri-ulcer barrier cream or spray, and the application of ActicoatⓇ on the wound bed. More or less alginate will be applied depending on the amount of exudate. A tertiary dressing of polyurethane foam or bandage will be applied according to the area and the nurse's discretion.

Timeline

Start date
2025-04-27
Primary completion
2027-03-01
Completion
2027-03-01
First posted
2024-03-07
Last updated
2025-06-26

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06297967. Inclusion in this directory is not an endorsement.